Alzheimer's disease (AD) is a neurodegenerative disorder that accounts for nearly 70% of
the more than 46 million dementia cases estimated worldwide. Although there is no cure for …

Dementia describes a clinical syndrome that encompasses difficulties in memory, language,
and behaviour that leads to impairments in activities of daily living. Alzheimer's disease is …

A combination of plasma phospho-tau (P-tau) and other accessible biomarkers might
provide accurate prediction about the risk of develo** Alzheimer's disease (AD) dementia …

Objective Tinnitus is the perception of sound without an external source. More than 50
million people in the United States have reported experiencing tinnitus, resulting in an …

Objective. To design a brief cognitive screener with acceptable sensitivity and specificity for
identifying subjects with cognitive impairment Design. Cohort one is assembled from a …

Abstract Since 1989, four Canadian Consensus Conferences on the Diagnosis and
Treatment of Dementia (CCCDTD) have provided evidence‐based dementia guidelines for …

Objectives To design a new, highly sensitive psychometric screening to identify patients with
mild cognitive impairment (MCI) and patients with dementia in the early stages of the …

The Patient Protection and Affordable Care Act added a new Medicare benefit, the Annual
Wellness Visit (AWV), effective January 1, 2011. The AWV requires an assessment to detect …

Background: Dementia is a large and growing problem but is often not diagnosed in its
earlier stages. Screening and earlier treatment could reduce the burden of suffering of this …

Dementia is characterized by the impairment of cognition and behavior of people over 65
years. Alzheimer's disease (AD) is the most prevalent neurodegenerative disorder in the …